Discontinued Operations (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) income from discontinued operations (net of tax)	$ (60,025,000)	$ 2,628,000	$ (61,794,000)	$ 4,463,000
Impairment of assets of discontinued operations			80,711,000
Antioxidant, Ibuprofen and Propofol Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	59,412,000	57,355,000	116,248,000	112,383,000
(Loss) income from discontinued operations	(80,174,000)	3,682,000	(82,687,000)	6,171,000
Income tax (benefit) expense	(20,149,000)	1,054,000	(20,893,000)	1,708,000
(Loss) income from discontinued operations (net of tax)	(60,025,000)	2,628,000	(61,794,000)	4,463,000
Impairment of assets of discontinued operations	80,711,000
Impairment of assets of discontinued operations, after tax	60,300,000
Cumulative foreign currency translation gains included in pre-tax impairment charge	16,700,000
Inventories	58,108,000		58,108,000
All other current assets	4,140,000		4,140,000
Net property, plant and equipment	52,367,000		52,367,000
Other intangibles, net of amortization	23,250,000		23,250,000
All other noncurrent assets	119,000		119,000
Assets of discontinued operations held for sale	137,984,000		137,984,000
Accounts payable	4,140,000		4,140,000
All other current liabilities	438,000		438,000
Noncurrent liabilities	6,600,000		6,600,000
Liabilities of discontinued operations held for sale	$ 11,178,000		$ 11,178,000